Maen Abdelrahim Download Headshot

Maen Abdelrahim, MD, PhD, B Pharm

  • Houston Methodist gastrointestinal medical oncologist
  • Assistant Professor of Medicine in Oncology, Houston Methodist Institute for Academic Medicine
  • Director, Houston Methodist Cockrell Center for Advanced Therapeutics
  • Assistant Professor of Medicine, Weill Cornell Medical College
Media Contact: Ashley White , 832.667.5849

Maen Abdelrahim, MD, PhD, B Pharm

Request Interview
Media Contact: Ashley White , 832.667.5849

Areas of Expertise

  • Cancer clinical trials
  • Cholangiocarcinoma
  • Clinical research
  • Colon cancer
  • Esophageal cancer
  • Gastric cancer
  • Gastrointestinal stromal tumors (GIST)
  • Liver cancer
  • Neuroendocrine cancers
  • Pancreatic cancer
  • Rectal cancer
  • Small intestine cancer
  • Translation research

Credentials

BACHELOR OF PHARMACY
Isra University - Amman, Jordan
DOCTOR OF PHILOSOPHY
Pharmacology and Toxicology | Texas A&M University - College Station, Texas
MEDICAL SCHOOL
Texas A&M University College of Medicine - Houston, Texas
RESIDENCY
Internal Medicine | Baylor College of Medicine - Houston, Texas
FELLOWSHIP
Medical Oncology | Duke University School of Medicine - Durham, N.C.

Publications

What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2022? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society
Bhat, M, Dondossola, D, Varghese, R, Czigany, Z, Emamaullee, J, Ghinolfi, D, Al-Adra, D, Bonaccorsi-Riani, E, Pang, L, Boteon, YL, Brüggenwirth, I, Pavan-Guimaraes, J, Ho, CM, Yuksel, M, Zarrinpar, A, Abdelrahim, M, Barbas, AS, Mas, V, Selzner, M & Martins, PN 2023, , Transplantation, vol. 107, no. 4, pp. 808-814. https://doi.org/10.1097/TP.0000000000004476

Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology
Abboud, K, Umoru, G, Esmail, A, Abudayyeh, A, Murakami, N, Al-Shamsi, HO, Javle, M, Saharia, A, Connor, AA, Kodali, S, Ghobrial, RM & Abdelrahim, M 2023, , Cancers, vol. 15, no. 5, 1433. https://doi.org/10.3390/cancers15051433

Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer
Burns, EA, Gee, K, Kieser, RB, Xu, J, Zhang, Y, Crenshaw, A, Muhsen, IN, Mylavarapu, C, Esmail, A, Shah, S, Umoru, G, Sun, K, Guerrero, C, Gong, Z, Heyne, K, Singh, M, Zhang, J, Bernicker, EH & Abdelrahim, M 2023, , Cancers, vol. 15, no. 1, 81. https://doi.org/10.3390/cancers15010081

Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer
Burns, EA, Gee, K, Kieser, RB, Xu, J, Zhang, Y, Crenshaw, A, Muhsen, IN, Mylavarapu, C, Esmail, A, Shah, S, Umoru, G, Sun, K, Guerrero, C, Gong, Z, Heyne, K, Singh, M, Zhang, J, Bernicker, EH & Abdelrahim, M 2022, , Cancers, vol. 15, no. 1. https://doi.org/10.3390/cancers15010081

Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer
Haque, E, Muhsen, IN, Esmail, A, Umoru, G, Mylavarapu, C, Ajewole, VB & Abdelrahim, M 2022, , Frontiers in Oncology, vol. 12, 992455. https://doi.org/10.3389/fonc.2022.992455

Intrahepatic cholangiocarcinoma: The role of liver transplantation, adjunctive treatments, and prognostic biomarkers
Connor, AA, Kodali, S, Abdelrahim, M, Javle, MM, Brombosz, EW & Ghobrial, RM 2022, , Frontiers in Oncology, vol. 12, 996710. https://doi.org/10.3389/fonc.2022.996710

Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening
Badheeb, M, Abdelrahim, A, Esmail, A, Umoru, G, Abboud, K, Al-Najjar, E, Rasheed, G, Alkhulaifawi, M, Abudayyeh, A & Abdelrahim, M 2022, , Current Oncology, vol. 29, no. 11, pp. 8693-8719. https://doi.org/10.3390/curroncol29110686

Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer
Haque, E, Esmail, A, Muhsen, I, Salah, H & Abdelrahim, M 2022, , Cancers, vol. 14, no. 22, 5615. https://doi.org/10.3390/cancers14225615


Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Experience
Abdelrahim, M, Esmail, A, Xu, J, Umoru, G, Al-Rawi, H, Saharia, A, Abudayyeh, A, Victor, D, McMillan, R, Kodali, S & Ghobrial, RM 2022, , Frontiers in Oncology, vol. 12, 908687. https://doi.org/10.3389/fonc.2022.908687

Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report
Abdelrahim, M, Esmail, A, Umoru, G, Westhart, K, Abudayyeh, A, Saharia, A & Ghobrial, RM 2022, , Current Oncology, vol. 29, no. 6, 4267, pp. 4267-4273. https://doi.org/10.3390/curroncol29060341

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
Cho, SM, Esmail, A, Raza, A, Dacha, S & Abdelrahim, M 2022, , Cancers, vol. 14, no. 11, 2641. https://doi.org/10.3390/cancers14112641

Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates
Kawashima, S, Joachim, K, Abdelrahim, M, Abudayyeh, A, Jhaveri, KD & Murakami, N 2022, , Korean Journal of Transplantation, vol. 36, no. 2, pp. 82-98. https://doi.org/10.4285/kjt.22.0013

Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series
Abdelrahim, M, Al-Rawi, H, Esmail, A, Xu, J, Umoru, G, Ibnshamsah, F, Abudayyeh, A, Victor, D, Saharia, A, McMillan, R, Al Najjar, E, Bugazia, D, Al-Rawi, M & Ghobrial, RM 2022, , Current Oncology, vol. 29, no. 5, pp. 3585-3594. https://doi.org/10.3390/curroncol29050290

Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge
Abdelrahim, M, Esmail, A, Al Saadi, N, Zsigmond, E, Al Najjar, E, Bugazia, D, Al-Rawi, H, Alsaadi, A & Kaseb, AO 2022, , Frontiers in Pharmacology, vol. 13, 848676. https://doi.org/10.3389/fphar.2022.848676

Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View
Abdelrahim, M, Esmail, A, Saharia, A, Abudayyeh, A, Abdel-Wahab, N, Diab, A, Murakami, N, Kaseb, AO, Chang, JC, Gaber, AO & Ghobrial, RM 2022, , Cancers, vol. 14, no. 7, 1760. https://doi.org/10.3390/cancers14071760

Pancreatic head vs pancreatic body/tail cancer: Are they different?
Sun, K, Mylavarapu, C, Crenshaw, A, Zhang, Y, Hsu, E, Xu, J, Niravath, M, Jones, SL, Ordonez, A & Abdelrahim, M 2022, , World journal of gastrointestinal oncology, vol. 14, no. 3, pp. 716-723. https://doi.org/10.4251/wjgo.v14.i3.716

Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience
Abdelrahim, M, Victor, D, Esmail, A, Kodali, S, Graviss, EA, Nguyen, DT, Moore, LW, Saharia, A, McMillan, R, Fong, JN, Uosef, A, Elshawwaf, M, Heyne, K & Ghobrial, RM 2022, , Cancers, vol. 14, no. 3, 650. https://doi.org/10.3390/cancers14030650

Utility of Cell-Free DNA Detection in Transplant Oncology
Reddy, T, Esmail, A, Chang, JC, Ghobrial, RM & Abdelrahim, M 2022, , Cancers, vol. 14, no. 3, 743. https://doi.org/10.3390/cancers14030743

What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2020–2021?—Report of the Basic and Translational Research Committee of the International Liver Transplantation Society
Czigany, Z, Brüggenwirth, IMA, Ekser, B, Abdelrahim, M, Bhat, M, Bonaccorsi-Riani, E, Chen, A, Emamaullee, J, Eymard, C, Ho, CM, Mas, VR, Zarrinpar, A, Yuksel, M, Martins, PN & Selzner, M 2022, , Transplantation, vol. 106, no. 2, pp. 227-233. https://doi.org/10.1097/TP.0000000000004003

Languages

  • English
  • Spanish